DBV Technologies (DBVT) Shares Outstanding (Weighted Average) (2015 - 2026)

DBV Technologies (DBVT) reported Shares Outstanding (Weighted Average) of $428.3 million for Q1 2026, up 317.38% year-over-year from $102.6 million in Q1 2025, and up 400153.11% quarter-over-quarter from $107008.0 in Q4 2025.

DBV Technologies (DBVT) Shares Outstanding (Weighted Average) (2015 - 2026) Analysis & Trends

DBV Technologies (DBVT) has 12 years of Shares Outstanding (Weighted Average) data on file, last reported at $428.3 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $428.3 million, up 317.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $428.3 million (up 317.38% YoY), and the FY2025 annual result was $107008.0, down 99.89% from the prior year.
  • Shares Outstanding (Weighted Average) improved to $428.3 million in Q1 2026 per DBVT's latest filing, from $107008.0 in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $428.3 million in Q1 2026 and troughed at $107008.0 in Q4 2025.
  • A 5-year average of $63.2 million and a median of $256693.0 in 2022 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) soared 39539.62% in 2024, then tumbled 99.89% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $251693.0 in 2022, then fell by 2.78% to $244693.0 in 2023, then soared by 39539.62% to $97.0 million in 2024, then plunged by 99.89% to $107008.0 in 2025, then soared by 400153.11% to $428.3 million in 2026.
  • Business Quant data shows DBVT's Shares Outstanding (Weighted Average) at $428.3 million in Q1 2026, $107008.0 in Q4 2025, and $195508.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn 428.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 428.30 Mn
Dec 31, 2025 107,008.00
Sep 30, 2025 195,508.00
Jun 30, 2025 195,508.00
Mar 31, 2025 102.62 Mn
Dec 31, 2024 97.00 Mn
Sep 30, 2024 244,693.00
Jun 30, 2024 244,693.00
Mar 31, 2024 96.18 Mn
Dec 31, 2023 244,693.00
Sep 30, 2023 94.80 Mn
Jun 30, 2023 94.15 Mn
Mar 31, 2023 93.97 Mn
Dec 31, 2022 251,693.00
Sep 30, 2022 251,693.00
Jun 30, 2022 66.05 Mn
Mar 31, 2022 256,693.00
Dec 31, 2021 256,693.00
Sep 30, 2021 256,693.00
Mar 31, 2021 54.88 Mn